EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Coeptis Therapeutics Holdings, Inc. (COEP) had EBIT Margin of -2252.94% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.20M |
|
$-3.53M |
|
$0.05M |
|
$0.16M |
|
$4.72M |
|
$-4.52M |
|
$0.19M |
|
$-4.33M |
|
$-4.33M |
|
$-4.33M |
|
$-4.33M |
|
$-4.33M |
|
$-4.33M |
|
$-4.52M |
|
$-3.84M |
|
3.71M |
|
3.71M |
|
$-1.17 |
|
$-1.17 |
|
| Balance Sheet Financials | |
$3.69M |
|
$0.01M |
|
$8.50M |
|
$12.19M |
|
$4.48M |
|
$0.15M |
|
$0.64M |
|
$5.11M |
|
$7.08M |
|
$6.63M |
|
$7.08M |
|
4.17M |
|
| Cash Flow Statement Financials | |
$-4.76M |
|
-- |
|
$6.23M |
|
$0.53M |
|
$2.00M |
|
$1.46M |
|
$4.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.83 |
|
-- |
|
-- |
|
0.02 |
|
0.18 |
|
77.50% |
|
-2252.94% |
|
|
EBIT Margin |
-2252.94% |
-- |
|
-2159.94% |
|
-1761.30% |
|
$-4.76M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
6.69 |
|
13.45 |
|
-61.22% |
|
-65.39% |
|
-35.55% |
|
-59.95% |
|
$1.70 |
|
$-1.28 |
|
$-1.28 |
|